| MTD | QTD | YTD | 1 Year | 3 Years | 5 Years |
| 1.56% | 12.96% | 26.96% | 58.76% | 30.52% | 48.74% |
| Tick | Name | Grade | 1 Mo. | |
|---|---|---|---|---|
| 3 | TGX | Theragenics Cor | 37.42 % | |
| 4 | SUPN | Supernus Pharma | 26.92 % | |
| 5 | ACRX | AcelRx Pharmace | 23.26 % | |
| 6 | SLXP | Salix Pharmaceu | 19.92 % | |
| 7 | FURX | Furiex Pharmace | 19.7 % | |
| 8 | WX | Wuxi Pharmatech | 19.44 % | |
| 9 | DSCI | Derma Sciences, | 18.01 % | |
| 10 | SNTS | Santarus, Inc. | 17.76 % | |
| 11 | ICLR | Icon Plc | 12.64 % | |
| 12 | JAZZ | Jazz Pharmaceut | 11.53 % | |
| 15 | UTHR | United Therapeutics Corp. | 10.89% |
| Tick | Name | Grade | 3 Mo. | |
|---|---|---|---|---|
| 1 | SNTS | Santarus, Inc. | 68.53 % | |
| 2 | OSIR | Osiris Therapeu | 56.19 % | |
| 3 | PCRX | Pacira Pharmace | 40.96 % | |
| 4 | ACRX | AcelRx Pharmace | 36.21 % | |
| 5 | RGLS | Regulus Therape | 34.72 % | |
| 6 | TGX | Theragenics Cor | 33.78 % | |
| 7 | ANIK | Anika Therapeut | 28.5 % | |
| 8 | WX | Wuxi Pharmatech | 28.08 % | |
| 9 | AMPE | Ampio Pharmaceu | 22.14 % | |
| 10 | SLXP | Salix Pharmaceu | 20.46 % | |
| 17 | UTHR | United Therapeutics Corp. | 17.44% |
| Tick | Name | Grade | 6 Mo. | |
|---|---|---|---|---|
| 1 | SNTS | Santarus, Inc. | 138.8 % | |
| 2 | FURX | Furiex Pharmace | 106.11 % | |
| 3 | PCRX | Pacira Pharmace | 81.75 % | |
| 4 | ACRX | AcelRx Pharmace | 70.02 % | |
| 5 | RGLS | Regulus Therape | 58.32 % | |
| 6 | ALR | Alere, Inc. | 47.26 % | |
| 7 | SLXP | Salix Pharmaceu | 43.54 % | |
| 8 | AMPE | Ampio Pharmaceu | 42.12 % | |
| 9 | SIGA | SIGA Technologi | 40.4 % | |
| 10 | TGX | Theragenics Cor | 36.49 % | |
| 21 | UTHR | United Therapeutics Corp. | 29.28% |
| Tick | Name | Grade | 1 Yr. | |
|---|---|---|---|---|
| 1 | SNTS | Santarus, Inc. | 282.82 % | |
| 2 | PCRX | Pacira Pharmace | 176.95 % | |
| 3 | FURX | Furiex Pharmace | 131.75 % | |
| 4 | ACRX | AcelRx Pharmace | 112.65 % | |
| 5 | SNTA | Synta Pharmaceu | 85.68 % | |
| 6 | OSIR | Osiris Therapeu | 84.54 % | |
| 7 | AMPE | Ampio Pharmaceu | 73.7 % | |
| 8 | UTHR | United Therapeu | 58.76 % | |
| 9 | VRX | Valeant Pharmac | 56.59 % | |
| 10 | DSCI | Derma Sciences, | 53.66 % |
| Tick | Name | Grade | 3 Yr. | |
|---|---|---|---|---|
| 1 | SNTS | Santarus, Inc. | 679.02 % | |
| 2 | JAZZ | Jazz Pharmaceut | 632.5 % | |
| 3 | VRX | Valeant Pharmac | 398.14 % | |
| 4 | DSCI | Derma Sciences, | 171.4 % | |
| 5 | AMRN | Amarin Corp. Pl | 151.46 % | |
| 6 | SNTA | Synta Pharmaceu | 136.86 % | |
| 7 | ANIK | Anika Therapeut | 128.4 % | |
| 8 | PRGO | The Perrigo Co. | 101.52 % | |
| 9 | OSIR | Osiris Therapeu | 75.96 % | |
| 10 | AGN | Allergan, Inc. | 68.36 % | |
| 24 | UTHR | United Therapeutics Corp. | 31.66% |